UNSPSC 51383000: Nonsteroidal anti inflammatory imidazoles

Nonsteroidal anti inflammatory drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.

UNSPSC 51383000 Nonsteroidal anti-inflammatory imidazoles, a Class code, does not align with the state and local opportunities recently tagged under it. The source records show procurement of naloxone (an opioid antagonist, not an NSAID), direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products—none of which fall within the nominal scope of nonsteroidal anti-inflammatory imidazole compounds. The code shows a significant classification mismatch in current state and local procurement activity, suggesting either systematic tagging errors in the underlying database or discontinuity between the UNSPSC taxonomy definition and how issuing bodies are categorizing pharmaceutical procurement in practice.

The three recent opportunities span issuing bodies from county health departments (Seminole County, Florida) to state health agencies (Texas Health and Human Services Commission) to multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving Minnesota and Oregon). The Seminole County IFB (IFB60459723LAS, due July 26, 2023) sought naloxone and drug deactivation systems on an annual basis with quarterly deliveries. The Texas HHS RFI (HHS0017013, posted April 3, 2026) was exploratory market research on direct-to-manufacturer prescription fulfillment models. The Minnesota MMCAP RFP (S1070000015802, due March 26, 2026) solicited generic pharmaceuticals and OTC products through authorized wholesalers for state and local government facilities. Geographic activity spans Florida, Texas, Minnesota, and Oregon, though the limited sample and category misalignment make it difficult to characterize sustained procurement demand under this specific code.